MX9207440A - Antagonistas de la bradiquinina para el tratamiento de pancreatitis aguda. - Google Patents
Antagonistas de la bradiquinina para el tratamiento de pancreatitis aguda.Info
- Publication number
- MX9207440A MX9207440A MX9207440A MX9207440A MX9207440A MX 9207440 A MX9207440 A MX 9207440A MX 9207440 A MX9207440 A MX 9207440A MX 9207440 A MX9207440 A MX 9207440A MX 9207440 A MX9207440 A MX 9207440A
- Authority
- MX
- Mexico
- Prior art keywords
- gly
- hyp
- pro
- substituted
- benzoyl
- Prior art date
Links
- 206010033645 Pancreatitis Diseases 0.000 title abstract 2
- 206010033647 Pancreatitis acute Diseases 0.000 title 1
- 201000003229 acute pancreatitis Diseases 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- -1 mercapto, hydroxyphenyl Chemical group 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 125000002038 D-arginyl group Chemical group N[C@@H](C(=O)*)CCCNC(=N)N 0.000 abstract 1
- SRBFZHDQGSBBOR-AGQMPKSLSA-N D-lyxopyranose Chemical group O[C@@H]1COC(O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-AGQMPKSLSA-N 0.000 abstract 1
- COLNVLDHVKWLRT-MRVPVSSYSA-N D-phenylalanine Chemical compound OC(=O)[C@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-MRVPVSSYSA-N 0.000 abstract 1
- LEIKGVHQTKHOLM-IUCAKERBSA-N Pro-Pro-Gly Chemical compound OC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 LEIKGVHQTKHOLM-IUCAKERBSA-N 0.000 abstract 1
- 239000003152 bradykinin antagonist Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- FXHCFPUEIDRTMR-UHFFFAOYSA-N hydron;1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid;chloride Chemical compound Cl.C1=CC=C2CNC(C(=O)O)CC2=C1 FXHCFPUEIDRTMR-UHFFFAOYSA-N 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 108010087846 prolyl-prolyl-glycine Proteins 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/043—Kallidins; Bradykinins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/18—Kallidins; Bradykinins; Related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La invención se refiere al uso de antagonistas de la bradiquinina de la fórmula R1 - A - B - C - D - E - F - G - H - I - J - K - R2, en la cual R1 representa hidrógeno, alcanoilo C1-C4 que puede estar sustituido con mercapto, hidroxifenilo, (4-benzoil) fenoxi o representa (4-benzoil)benzoil-Lys; A representa D-Arg o D-Lyx o significa un enlace directo; B representa Arg, que puede estar sustituido con NO2 O toluol-4-sulfonilo o representa Lys, que puede estar sustituido con toluol-4-sulfonilo o CO-NH-C6H5, o significa un enlace directo; C representa Hyp-Pro-Gly, Pro-Hyp-Gly, Pro-Pro-Gly o deshidroPro-Hyp-Gly; E representa Thi, Phe, Leu o Cha; F representa Ser o Cys; G representa D-Tic, D-Phe o D-Hyp sustituido con alcoxi C1-C4; J representa Tic, Aoc o Oic; K representa Arg o Ahx, o significa un enlace directo; R2 es hidroxi o amino; y sus sales fisiológicamente tolerables, para los tratamientos de la pancreatitis ayuda, a agentes farmacéuticos que los contienen y a su empleo par ala preparación de composiciones farmacéuticas apropiadas.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP91122055 | 1991-12-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9207440A true MX9207440A (es) | 1993-07-01 |
Family
ID=8207466
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9207440A MX9207440A (es) | 1991-12-21 | 1992-12-18 | Antagonistas de la bradiquinina para el tratamiento de pancreatitis aguda. |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US5670619A (es) |
| EP (1) | EP0548825B1 (es) |
| JP (1) | JP3588472B2 (es) |
| KR (1) | KR930012034A (es) |
| CN (1) | CN1073603A (es) |
| AT (1) | ATE152733T1 (es) |
| AU (1) | AU662188B2 (es) |
| BG (1) | BG97168A (es) |
| BR (1) | BR9205062A (es) |
| CA (1) | CA2085781C (es) |
| CY (1) | CY2116B1 (es) |
| CZ (1) | CZ375692A3 (es) |
| DE (1) | DE69219574T2 (es) |
| DK (1) | DK0548825T3 (es) |
| ES (1) | ES2101017T3 (es) |
| FI (1) | FI925782A (es) |
| GR (1) | GR3024179T3 (es) |
| HU (1) | HU214056B (es) |
| IL (1) | IL104163A0 (es) |
| MA (1) | MA22743A1 (es) |
| MX (1) | MX9207440A (es) |
| NO (1) | NO924925L (es) |
| PL (1) | PL297044A1 (es) |
| SI (1) | SI9200406A (es) |
| TW (1) | TW199863B (es) |
| YU (1) | YU108192A (es) |
| ZA (1) | ZA929829B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7105172B1 (en) | 1999-11-18 | 2006-09-12 | Bolla John D | Treatment of rosacea |
| US20040248809A1 (en) * | 2003-02-07 | 2004-12-09 | Aventis Pharma Deutschland Gmbh | Use of antagonists of the bradykinin B2 receptor for the treatment of osteoarthrosis |
| RU2425669C1 (ru) * | 2010-04-13 | 2011-08-10 | Общество С Ограниченной Ответственностью "Гамаветфарм" | Средство для профилактики и лечения острого и хронического панкреатита |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0009010B1 (en) * | 1978-07-18 | 1983-03-02 | Kabi AB | Bradykinin inhibiting tripeptide derivatives, process for their preparation and pharmaceutical preparations containing them |
| US4693993A (en) * | 1985-06-13 | 1987-09-15 | Stewart John M | Bradykinin antagonist peptides |
| US4801613A (en) * | 1985-06-13 | 1989-01-31 | Nova Technology Limited Partnership | Bradykinin antagonist peptides |
| US4923963A (en) * | 1987-09-02 | 1990-05-08 | Nova Technology Limited Partnership | Bradykinin antagonist peptides |
| US5162497A (en) * | 1987-09-24 | 1992-11-10 | The Administrators Of The Tulane Educational Fund | Bradykinin analogs with non-peptide bond |
| DE4013270A1 (de) * | 1990-04-26 | 1991-10-31 | Hoechst Ag | Peptide mit bradykinin-antagonistischer wirkung |
| DE3926822A1 (de) * | 1989-08-14 | 1991-02-21 | Hoechst Ag | Peptide mit bradykinin-antagonistischer wirkung |
| IE63490B1 (en) * | 1988-11-24 | 1995-05-03 | Hoechst Ag | Peptides having bradykinin antagonist action |
| DE69012142D1 (de) * | 1989-12-08 | 1994-10-06 | Univ Boston | Acylierte bradykininantagonisten und deren verwendung. |
| EP0451791A2 (de) * | 1990-04-12 | 1991-10-16 | Hoechst Aktiengesellschaft | Langwirksame Liposomenpräparate von Peptidarzneistoffen und Verfahren zu ihrer Herstellung |
-
1992
- 1992-03-26 TW TW081102310A patent/TW199863B/zh active
- 1992-12-14 BG BG097168A patent/BG97168A/bg unknown
- 1992-12-16 MA MA23033A patent/MA22743A1/fr unknown
- 1992-12-17 PL PL29704492A patent/PL297044A1/xx unknown
- 1992-12-17 AU AU30212/92A patent/AU662188B2/en not_active Ceased
- 1992-12-18 NO NO92924925A patent/NO924925L/no unknown
- 1992-12-18 AT AT92121558T patent/ATE152733T1/de active
- 1992-12-18 DK DK92121558.8T patent/DK0548825T3/da active
- 1992-12-18 ES ES92121558T patent/ES2101017T3/es not_active Expired - Lifetime
- 1992-12-18 YU YU108192A patent/YU108192A/sh unknown
- 1992-12-18 DE DE69219574T patent/DE69219574T2/de not_active Expired - Lifetime
- 1992-12-18 ZA ZA929829A patent/ZA929829B/xx unknown
- 1992-12-18 FI FI925782A patent/FI925782A/fi unknown
- 1992-12-18 CA CA002085781A patent/CA2085781C/en not_active Expired - Lifetime
- 1992-12-18 BR BR9205062A patent/BR9205062A/pt not_active Application Discontinuation
- 1992-12-18 MX MX9207440A patent/MX9207440A/es unknown
- 1992-12-18 EP EP92121558A patent/EP0548825B1/en not_active Expired - Lifetime
- 1992-12-18 JP JP33773592A patent/JP3588472B2/ja not_active Expired - Lifetime
- 1992-12-18 CZ CS923756A patent/CZ375692A3/cs unknown
- 1992-12-18 IL IL104163A patent/IL104163A0/xx unknown
- 1992-12-19 KR KR1019920024742A patent/KR930012034A/ko not_active Application Discontinuation
- 1992-12-21 SI SI19929200406A patent/SI9200406A/sl unknown
- 1992-12-21 HU HU9204074A patent/HU214056B/hu not_active IP Right Cessation
- 1992-12-21 CN CN92114564A patent/CN1073603A/zh active Pending
-
1994
- 1994-04-22 US US08/232,338 patent/US5670619A/en not_active Expired - Lifetime
-
1997
- 1997-07-22 GR GR970401824T patent/GR3024179T3/el unknown
-
1998
- 1998-09-29 CY CY9800034A patent/CY2116B1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2101017T3 (es) | 1997-07-01 |
| ZA929829B (en) | 1994-02-16 |
| JPH05255107A (ja) | 1993-10-05 |
| AU662188B2 (en) | 1995-08-24 |
| FI925782A0 (fi) | 1992-12-18 |
| DE69219574D1 (de) | 1997-06-12 |
| BR9205062A (pt) | 1993-09-28 |
| FI925782A (fi) | 1993-06-22 |
| JP3588472B2 (ja) | 2004-11-10 |
| EP0548825A1 (en) | 1993-06-30 |
| NO924925D0 (no) | 1992-12-18 |
| DK0548825T3 (da) | 1997-11-03 |
| TW199863B (es) | 1993-02-11 |
| BG97168A (bg) | 1993-12-24 |
| CA2085781A1 (en) | 1993-06-22 |
| DE69219574T2 (de) | 1997-11-13 |
| PL297044A1 (en) | 1993-09-06 |
| CN1073603A (zh) | 1993-06-30 |
| SI9200406A (en) | 1993-06-30 |
| HU214056B (en) | 1997-12-29 |
| IL104163A0 (en) | 1993-05-13 |
| ATE152733T1 (de) | 1997-05-15 |
| YU108192A (sh) | 1995-12-04 |
| MA22743A1 (fr) | 1993-07-01 |
| NO924925L (no) | 1993-06-22 |
| GR3024179T3 (en) | 1997-10-31 |
| CA2085781C (en) | 2003-09-23 |
| EP0548825B1 (en) | 1997-05-07 |
| US5670619A (en) | 1997-09-23 |
| CY2116B1 (en) | 2002-04-26 |
| CZ375692A3 (en) | 1993-12-15 |
| HU9204074D0 (en) | 1993-04-28 |
| KR930012034A (ko) | 1993-07-20 |
| HUT63336A (en) | 1993-08-30 |
| AU3021292A (en) | 1993-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0009564A (pt) | Utilização de inibidores da cyp2d6 em terapias de combinação | |
| PE117299A1 (es) | Derivados de resorcinol | |
| ECSP045520A (es) | Metodos de tratamiento con inhibidores de la ptec y agentes antihipertensivos | |
| CR7786A (es) | Anticuerpos neutralizantes contra gdf-8 y el uso de los mismos | |
| CO5611176A2 (es) | Administracion de agentes para el tratamiento de inflamacion | |
| AR003574A1 (es) | Compuestos cíclicos, inhibidores de la adhesión. | |
| PT883687E (pt) | Receptores de quimiocinas c-c, ckr-5, cc, os seus derivados e as suas utilizacoes | |
| NO974270L (no) | Insulinderivater | |
| Marala et al. | Dual regulation of atrial natriuretic factor-dependent guanylate cyclase activity by ATP | |
| ECSP045474A (es) | 1-(aminoalquil)-3-sulfonilazaindoles como ligandos de 5-hidroxitriptamina-6 | |
| PL1755630T3 (pl) | Kompozycje farmaceutyczne z brodaczki włosowatej i dziurawca oraz ich zastosowanie | |
| BR9811948A (pt) | Secretores de hormÈnio do crescimento | |
| ES2145997T3 (es) | Composiciones de aminoacidos y uso de las mismas en la nutricion clinica. | |
| MX9207440A (es) | Antagonistas de la bradiquinina para el tratamiento de pancreatitis aguda. | |
| Gechtman et al. | Synthetic peptides derived from the sequence around the plasmin cleavage site in vitronectin: Use in mapping the PAI-1 binding site | |
| MX9204212A (es) | Preparado de combinacion farmaceutico. | |
| CR7622A (es) | Secuencias del control del gen de corina humano | |
| TH13940EX (th) | เบรดีไคนิน-แอนตาโกนิส สำหรับใช้บำบัดตับอ่อนอักเสบเฉียบพลัน | |
| TH13940A (th) | เบรดีไคนิน-แอนตาโกนิส สำหรับใช้บำบัดตับอ่อนอักเสบเฉียบพลัน | |
| ES2058473T3 (es) | Analogos de tuftsina y vacunas que contienen estos como coadyuvantes. | |
| AR004497A1 (es) | Un análogo hexapéptido cíclico de somatostatina, procedimiento para prepararlos y las composiciones farmacéuticas que los contienen y el uso de dicho hexapéptido para la preparación de una composición farmacéutica. | |
| ES2131468B1 (es) | Uso de la melatonina en el tratamiento de las enfermedades neurodegenerativas. | |
| AR127281A1 (es) | Dendrones peptídicos y métodos de uso de los mismos | |
| PE20241065A1 (es) | Composiciones y metodos para el tratamiento de la perdida de audicion asociada a kcnq4 | |
| RU92016227A (ru) | Лекарственная композиция, включающая антагонисты брадикинина, используемая в лечении острого панкреатита, способ ее получения и использование |